Leveraging the Electronic Health Records for Population Health: A Case Study of Patients With Markedly Elevated Blood Pressure

Abstract

Background The digital transformation of medical data provides opportunities to perform digital population health surveillance and identify people inadequately managed in usual care. We leveraged the electronic health records of a large health system to identify patients with markedly elevated blood pressure and characterize their follow-up care pattern. Methods and Results We included 373 861 patients aged 18 to 85 years, who had at least 1 outpatient encounter in the Yale New Haven Health System between January 2013 and December 2017. We described the prevalence and follow-up pattern of patients with at least 1 systolic blood pressure (SBP) ≥160 mm Hg or diastolic blood pressure (DBP) ≥100 mm Hg and patients with at least 1 SBP ≥180 mm Hg or DBP ≥120 mm Hg. Of 373 861 patients included, 56 909 (15.2%) had at least 1 SBP ≥160 mm Hg or DBP ≥100 mm Hg, and 10 476 (2.8%) had at least 1 SBP ≥180 mm Hg or DBP ≥120 mm Hg. Among patients with SBP ≥160 mm Hg or DBP ≥100 mm Hg, only 28.3% had a follow visit within 1 month (time window of follow-up recommended by the guideline) and 19.9% subsequently achieved control targets (SBP <130 mm Hg and DBP <80 mm Hg) within 6 months. Follow-up rate at 1 month and control rate at 6 months for patients with SBP ≥180 mm Hg or DBP ≥120 mm Hg was 31.9% and 17.2%. Conclusions Digital population health surveillance with an electronic health record identified a large number of patients with markedly elevated blood pressure and inadequate follow-up. Many of these patients subsequently failed to achieve control targets.

Keywords: electronic health records; high blood pressure; hypertension; quality of care; risk factor; surveillance.

Figure 1

Flow diagram for study cohort identification. YNHHS indicates Yale–New Haven Health System.

Figure 2

Duration between blood pressure elevated measurement and follow‐up visit among patients with (A) SBP ≥160 mm Hg or DBP ≥100 mm Hg, and (B) SBP ≥180 mm Hg or DBP ≥120 mm Hg who had follow‐up visits. DBP indicates diastolic blood pressure; and SBP, systolic blood pressure.

Figure 3

Duration between blood pressure elevated measurement and control target achievement among patients with (A) SBP ≥160 mm Hg or DBP ≥100 mm Hg, and (B) SBP ≥180 mm Hg or DBP ≥120 mm Hg who achieved control targets. DBP indicates diastolic blood pressure; and SBP, systolic blood pressure.